Search clinical trials for: Reolysin
Total 35 results
-
Oncolytics BiotechCompletedOsteosarcoma | Leiomyosarcoma | Fibrosarcoma | Sarcoma, Synovial | Ewing Sarcoma Family Tumors | Malignant Fibrous HistiocytomaUnited States
-
Oncolytics BiotechCompletedMalignant GliomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV MelanomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Light Chain Deposition DiseaseUnited States
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedNon Small Cell Lung CancerCanada
-
Canadian Cancer Trials GroupOncolytics BiotechCompletedMetastatic Breast CancerCanada
-
University of LeedsYorkshire Cancer ResearchWithdrawnMelanoma | Cancer of Skin
-
Northwestern UniversityNational Cancer Institute (NCI)TerminatedPancreatic Adenocarcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8United States
-
Oncolytics BiotechCompletedCarcinoma, Squamous Cell of the Head and NeckUnited States
-
Oncolytics BiotechUniversity of TexasCompletedMetastatic MelanomaUnited States
-
Oncolytics BiotechUniversity of TexasCompletedMetastatic or Recurrent Squamous Cell Carcinoma of the LungUnited States
-
Oncolytics BiotechCompletedCarcinoma, Non-small Cell LungUnited States
-
Oncolytics BiotechCompletedCarcinoma, Squamous Cell of the Head and NeckUnited States, Canada, Spain, Belgium, United Kingdom, Greece, Germany, Hungary, Poland, Slovenia, France, Italy, Russian Federation
-
Intralytix, Inc.RecruitingVancomycin-Resistant Enterococcal ColonizationUnited States
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
Oncolytics BiotechWithdrawnMuscle-invasive Transitional Cell Carcinoma of the Bladder
-
Oncolytics BiotechUniversity of TexasCompletedMetastatic Pancreatic AdenocarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedGlioma | Recurrent Childhood Medulloblastoma | Childhood Atypical Teratoid/Rhabdoid Tumor | Diffuse Intrinsic Pontine Glioma | Refractory Brain Neoplasm | Recurrent Childhood Anaplastic Oligodendroglioma | Recurrent Childhood Glioblastoma | Recurrent Primitive Neuroectodermal Tumor | Childhood Astrocytoma and other conditionsUnited States
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Canadian Cancer Trials GroupOncolytics BiotechCompleted
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Oncolytics BiotechSOLTI Breast Cancer Research GroupTerminated
-
Luye Pharma Group Ltd.CompletedSchizophrenia | Schizoaffective Disorder | Schizo Affective DisorderUnited States
-
Canadian Cancer Trials GroupOncolytics BiotechCompleted
-
National Cancer Institute (NCI)CompletedPancreatic Ductal Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Pancreatic Cancer | Pancreatic Acinar Cell CarcinomaUnited States
-
Oncolytics BiotechCompletedPancreatic AdenocarcinomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); City of Hope Medical Center and other collaboratorsCompletedRecurrent Plasma Cell MyelomaUnited States
-
Oncolytics BiotechMontefiore Medical CenterCompletedKRAS Mutant Metastatic Colorectal CancerUnited States
-
Hadassah Medical OrganizationUnknownDiabetes Mellitus | Iron Metabolism Disorders | Optic Atrophy | Sensorineural Hearing Loss | Platelet Dysfunction | Gastroduodenal UlcerIsrael
-
University of Southern CaliforniaNational Cancer Institute (NCI); Oncolytics BiotechCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedAnemia | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States